CEACAM19

CEACAM19
Identifiers
Aliases	CEACAM19, CEAL1, CEACM19, carcinoembryonic antigen related cell adhesion molecule 19, CEA cell adhesion molecule 19
External IDs	OMIM: 606691; MGI: 2443001; HomoloGene: 49621; GeneCards: CEACAM19; OMA:CEACAM19 - orthologs
Gene location (Human)
Chr.	Chromosome 19 (human)[1]
End	44,684,359 bp[1]
Gene location (Mouse)
Chr.	Chromosome 7 (mouse)[2]
End	19,621,890 bp[2]
RNA expression pattern
	Top expressed in
	right uterine tube; ; tibial nerve; ; gastrocnemius muscle; ; body of pancreas; ; right lobe of liver; ; left ventricle; ; anterior pituitary; ; stromal cell of endometrium; ; skin of abdomen; ; sural nerve;
	Top expressed in
	lip; ; esophagus; ; zone of skin; ; stomach; ; urinary bladder; ; limb;
	More reference expression data
	n/a
Orthologs
	56971
	319930
	ENSG00000186567
	ENSMUSG00000049848
	Q7Z692
	Q3TQ88
	NM_001127893; NM_020219; NM_001389722
	NM_177036
	NP_001121365; NP_064604
	NP_796010
	Wikidata
View/Edit Human	View/Edit Mouse

Carcinoembryonic antigen-related cell adhesion molecule 19 is a carcinoembryonic antigen encoded in the human by the CEACAM19 gene. The expression of this gene is associated with breast cancer[5] and colorectal cancer[6]

References

GRCh38: Ensembl release 89: ENSG00000186567 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000049848 – Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Estiar MA, Esmaeili R, Zare AA, Farahmand L, Fazilaty H, Zekri A, et al. (November 2017). "High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer". Clinical and Experimental Medicine. 17 (4): 547–553. doi:10.1007/s10238-016-0442-1. PMID 27909883.
Dongxui S, Qinglong J, Bingjie Q, Guihua G (5 January 2020). "Expression of carcinoembryonic antigen-related cell adhesion molecule 19 and its prognostic significance in colorectal cancer". 中国医师进修杂志 [Chinese Journal of Continuing Education for Physicians] (in Chinese). 43 (1): 70–75. doi:10.3760/cma.j.issn.1673-4904.2020.01.017. ISSN 1673-4904.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000186567 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000049848 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[5] Estiar MA, Esmaeili R, Zare AA, Farahmand L, Fazilaty H, Zekri A, et al. (November 2017). "High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer". Clinical and Experimental Medicine. 17 (4): 547–553. doi:10.1007/s10238-016-0442-1. PMID 27909883.

[6] Dongxui S, Qinglong J, Bingjie Q, Guihua G (5 January 2020). "Expression of carcinoembryonic antigen-related cell adhesion molecule 19 and its prognostic significance in colorectal cancer". 中国医师进修杂志 [Chinese Journal of Continuing Education for Physicians] (in Chinese). 43 (1): 70–75. doi:10.3760/cma.j.issn.1673-4904.2020.01.017. ISSN 1673-4904.